Skip to content
Review

Tumor-nervous system crosstalk in PDAC: Current landscape, challenges, and future directions.

Nov 2026 · Cancer Letters · pp. 218949 · 0 citations · 177 references
Medicine

TL;DR

By synthesizing emerging clinical trials targeting neurotransmitter axes, dorsal root ganglia, and neurotrophic signaling, this work provides a forward-looking roadmap for integrating precision neuro-oncology with standard regimens to simultaneously alleviate cancer pain and overcome therapeutic resistance in PDAC.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal and treatment-refractory malignancies worldwide, largely driven by its uniquely desmoplastic and highly innervated microenvironment. Given the striking incidence of perineural invasion and its profound correlation with intractable cancer pain and early recurrence, tumor-nervous system crosstalk has emerged as a pivotal driver of PDAC progression. Neural components-including neurotransmitters, neurotrophic factors, axon guidance molecules, and specific sensory and autonomic networks (e.g., dorsal root ganglia and sympathetic nerves)-do not merely act as passive conduits, but actively orchestrate tumor genesis, metastasis, and immune evasion. Crucially, this neuro-stromal crosstalk actively drives chemoresistance by facilitating the dual-effect remodeling of tumor energy metabolism and detoxification networks. In this comprehensive review, we decode the multidimensional molecular mechanisms and reciprocal signaling cascades underpinning tumor-nervous system crosstalk. We critically evaluate the translational challenges of applying neurotherapy in clinical practice, encompassing mechanistic pleiotropy, neural plasticity, and visceral safety risks. Furthermore, by synthesizing emerging clinical trials targeting neurotransmitter axes, dorsal root ganglia, and neurotrophic signaling, we provide a forward-looking roadmap for integrating precision neuro-oncology with standard regimens to simultaneously alleviate cancer pain and overcome therapeutic resistance in PDAC.

View source

Similar papers

Review Open access Nov 2026

Neuro-immune-tumor microenvironment interactions in pancreatic cancer: mechanisms and targeted therapeutic strategies

Pancreatic cancer, particularly pancreatic ductal adenocarcinoma (PDAC), is highly aggressive and resistant to conventional treatment. Perineural invasion (PNI) and bidirectional neuroimmune signaling contribute to tumor progression, immune evasion, pain, and treatment resistance. This review integrates the morpholog...

Fu-Qiang Tian, Yan Cai, Yue-Hong Li et al. · 0 citations
Review Open access Sep 2026

Decoding neuro-tumor interactions in pancreatic cancer: mechanisms, immunosuppressive networks and therapeutic opportunities

A unified four-stage mechanistic model of PNI is proposed, encompassing mutual chemotaxis between tumors and nerves, adhesion and invasion at the tumor-nerve interface, extracellular matrix remodeling, and neural plasticity alterations, and defines the perineural invasion microenvironment as a neuro-immune privileged s...

Wei-Zuo Cheng, Hao-Tian Cao, Hao Hu et al. · 0 citations
Review Open access Oct 2026

Neuroimmune crosstalk in cancer: emerging immunotherapeutic opportunities

A review of progression from tumor-induced neural remodeling and neural-like cell states to the sensory, autonomic, enteric, and systemic neuroendocrine axes that regulate antitumor immunity and how spatial omics resolves these interactions in situ is considered.

Tian-Wei Dong, Hidde Ploeger, T. Eichwald et al. · 0 citations
Review Open access Sep 2026

Neural–tumor interactions: bidirectional regulatory mechanisms and nervous system-targeted tumor therapeutic strategies

This review focuses on tumors arising outside the central nervous system and their bidirectional interactions with peripheral nerves, summarizing the current evidence on the molecular mechanisms underlying these reciprocal interactions.

Yu-Zhe Huang, Tong Tong, Zhao-Yang Zeng et al. · 0 citations
Review Open access Sep 2026

Neural Remodeling Shapes a Nerve-Dependent Metastatic Ecosystem in Ovarian Cancer.

Ovarian cancer (OC) remains a highly lethal malignancy characterised by diffuse peritoneal dissemination and frequent treatment resistance. Beyond tumor-intrinsic alterations and classical stromal support, the peripheral nervous system is emerging as an important component of the tumor microenvironment. Here, we develo...

Li Ou, Chen-Zhao Feng, Chen Sun et al. · 1 citation
Review Open access Oct 2026

Tumor microenvironment-driven therapeutic resistance in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most treatment-refractory malignancies, with limited and often transient benefit from chemotherapy, targeted therapy, immunotherapy, and radiotherapy. Therapeutic resistance is increasingly recognized as an ecosystem-level process arising from reciprocal intera...

Hong-Jiao Li, Jia-Ning Cui, Xin Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.